中性粒细胞与淋巴细胞比值对择期肾下型EVAR术后短期和长期预后的影响
单中心回顾性队列研究纳入2011至2023年434例择期肾下型EVAR患者,评估中性粒细胞与淋巴细胞比值(NLR)对预后的影响。NLR≥2.4与短期主要不良事件(MAE)风险升高及8年生存率降低独立相关,且与主动脉再干预率升高相关,但EVAR失败率无差异。
要点
- NLR≥2.4是长期死亡率的尚可判别指标(AUC 0.62),并独立预测MAE(aOR 2.10)和死亡(aHR 1.07)。
- NLR≥2.4组8年生存率33.7%,低于NLR<2.4组的55.7%(P<0.001)。
- NLR≥2.4组免于主动脉再干预率70.2%,低于NLR<2.4组的80.0%(P=0.01,aHR 1.80)。
核心结论
- NLR似乎是预后标志物,合并症负担对其影响较小;EVAR术后NLR独立预测MAE和死亡。
- 随时间推移,NLR升高似乎与主动脉再干预增加相关,但两组失败率和失败模式似乎相似。
研究设计与样本
- 单中心回顾性队列研究,连续纳入2011至2023年接受择期EVAR的患者,共434例。
- 主要结局为短期主要不良事件(MAE)和长期死亡率;次要结局为免于EVAR失败、主动脉再干预及NLR预测因素。
- 二分类结局采用多变量逻辑回归分析;生存结局采用Kaplan-Meier和Cox回归分析。
主要发现
- NLR截断值2.4对长期死亡率为尚可判别指标(AUC 0.62),据此将患者二分为两组。
关键数值与推荐
- NLR截断值2.4用于分组,对长期死亡率的AUC为0.62。
临床怎么用
- 原文未据此给出推荐。
- 作者认为NLR似乎是预后标志物,EVAR术后独立预测MAE和死亡。
- 作者认为随时间推移NLR升高似乎与主动脉再干预增加相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neutrophil-to-lymphocyte ratio (NLR) is a readily available parameter, associated with long-term outcomes in cardiovascular conditions. This study aims to analyze the predictors of NLR and its impact on prognosis and disease-specific outcomes following endovascular aneurysm repair (EVAR). METHODS: Single-center retrospective cohort study. Consecutive patients who underwent elective EVAR (2011-2023) were considered. Primary outcome is short-term major adverse events (MAE) and long-term mortality. Secondary outcomes were freedom-from EVAR failure, aortic reintervention, and NLR predictors. Multivariable logistic regression analyses were performed for binary outcomes. Survival outcomes were analyzed through Kaplan-Meier and Cox regression analyses. RESULTS: Overall, 434 patients were included. A 2.4 NLR cutoff was a fair discriminator for long-term-mortality (area under the curve, 0.62), and groups were dichotomized according to this premise. Increasing age (adjusted odds ratio [aOR]: 1.06; 1.03-1.09, per 1-year increase) and a pulmonary comorbidity (aOR: 1.91; 1.24-2.96) associated to NLR ≥ 2.4. No significant association between comorbidity burden and NLR was observed. MAE occurred more often if NLR ≥ 2.4 (6.2 vs. 11.6% high-NLR, P = 0.049; NLR ≥ 2.4 aOR: 2.10; 1.01-4.36). At 8-years follow-up, survival estimates favored NLR < 2.4 (55.7% vs. 33.7% high-NLR, P < 0.001, NLR ≥ 2.4 adjusted hazard ratio [aHR]: 1.07; 1.05-1.98), without differences in freedom-from EVAR failure (70.6 vs. 68.2% high-NLR, P = 0.27, NLR ≥ 2.4 aHR: 1.26; 0.82-1.94). Conversely, NLR ≥ 2.4 associated with lower freedom from aortic reinterventions (80.0% vs. 70.2% high-NLR, P = 0.01, NLR ≥ 2.4 aHR: 1.80; 1.08-3.01). CONCLUSION: NLR appears as a prognostic marker with reduced impact of comorbidity burden. Following EVAR, it independently predicts MAE and mortality. Over time, elevated NLR appears associated with increased aortic reinterventions, although rates and mode of failure seem similar across groups.
引用
- Ribeiro TF, Soares Ferreira R, Amaral C, et al. The Impact of Neutrophil-to-Lymphocyte Ratio on Short- and Long-Term Prognosis Following Elective Infrarenal EVAR. Ann Vasc Surg. 2025. PMID: 39880285. doi:10.1016/j.avsg.2025.01.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。